ICICI Securities Recommends Buying Max Healthcare, Sets Rs 1,300 Target

ICICI Securities cited Q2FY27 revenue and EBITDA growth of about 18% year over year, alongside a 13% rise in occupied bed days and 8% growth in ARPP.